GPT and infection: Reasons for treatment failure were persistent bacteremia (3/12; 25%) or clinical or laboratory findings of infection (3/12; 25%), despite at least 72 h of appropriate lock therapy or recurrence (3/12; 25%), or reinfection (3/12; 25%) within 90 days after the suspension of ALT.